Treatment patterns and survival of low and intermediate‐risk prostate cancer in end‐stage kidney disease: A retrospective population cohort study
Open Access
- 16 January 2023
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 12 (7) , 7941-7950
Abstract
Background: In accordance with guidelines, observation with or without active surveillance for low-risk prostate cancer increased in recent years in the general population. We compared treatment patterns and mortality for low- and intermediate-risk prostate cancer and mortality rates among end-stage kidney disease (ESKD) and non-ESKD patients.Methods: This is a retrospective population-based observational cohort study of Surveillance, Epidemiology, and End Results-Medicare data of men aged 66 years and older with localized prostate cancer (2004-2015). ESKD status was determined using Medicare billing codes. Multivariable logistic regression models and Cox-proportional hazards models were used to study definitive treatment patterns and mortality, respectively.Results: For low-risk prostate cancer, dialysis patients (N = 83) had lower but not statistically significant odds (OR, 0.74; 95% CI: 0.48-1.16) of receiving definitive treatment than non-ESKD patients (N = 24,935). For those with intermediate-risk prostate cancer, dialysis patients (N = 254) had lower odds to receive definitive treatment (OR, 0.54; 95% CI: 0.42-0.72) than non-ESKD patients (N = 60,883). From 2004-2010 to 2011-2015, for patients with low-risk prostate cancer, while the receipt of definitive treatment for non-ESKD patients trended down from 72% to 48%, it trended up for dialysis patients from 55% to 65%. Kidney transplant patients (N = 33 for low-risk and N = 91 for intermediate-risk) had lower rates of definitive treatment for low-risk and similar rates of treatment for intermediate-risk prostate cancer compared to non-ESKD patients.Conclusions: The disparity in definitive treatment rates for low-risk prostate cancer among dialysis patients exists despite their high mortality, compared to the general population.Keywords
This publication has 21 references indexed in Scilit:
- Contemporary Management of Prostate Cancer Patients Suitable for Active Surveillance: A North American Population-based StudyEuropean Urology Focus, 2018
- Prostate-specific antigen screening and prostate cancer treatment in renal transplantation candidates: A survey of U.S. transplantation centersUrologic Oncology: Seminars and Original Investigations, 2016
- Utility of Prostate Cancer Screening in Kidney Transplant CandidatesJournal of the American Society of Nephrology, 2015
- Variation in Use of Active Surveillance among Men Undergoing Expectant Treatment for Early Stage Prostate CancerJournal of Urology, 2014
- Spectrum of Cancer Risk Among US Solid Organ Transplant RecipientsJAMA, 2011
- Comparison of Stage at Diagnosis of Cancer in Patients Who Are on Dialysis versus the General PopulationClinical Journal of the American Society of Nephrology, 2007
- Cancer after Kidney Transplantation in the United StatesAmerican Journal of Transplantation, 2004
- Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimensThe Lancet, 1998
- Risk of neoplasia in renal transplant patientsThe Lancet, 1995
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994